Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp (TCNNF) provides comprehensive medical and recreational cannabis products through its vertically integrated operations across multiple U.S. states. This news hub offers investors and stakeholders direct access to official corporate announcements, financial disclosures, and operational updates.
Discover timely information about earnings reports, regulatory compliance milestones, dispensary expansions, and product innovations. Our curated collection ensures transparent tracking of Trulieve's market leadership in cultivation practices and retail operations within strictly regulated environments.
Key updates include strategic acquisitions, new market entries, sustainability initiatives, and advancements in medical cannabis research. All content originates from verified company communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of TCNNF's operational developments and industry positioning. Check regularly for updates on one of the cannabis sector's most influential multi-state operators.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announces its participation in several upcoming conferences in June 2022. Key events include the 19th Annual Craig-Hallum Institutional Investor Conference on June 1, the Jefferies Cannabis Summit on June 2 in New York, an Analyst Event with a bus tour in Florida on June 7, and the Annual Shareholder Meeting on June 8, accessible online. Trulieve, a leading cannabis company operating in 11 states, is focused on growth through its hub strategy and aims to provide high-quality products to enhance customer experience.
Trulieve Cannabis Corp. (OTCQX: TCNNF) reported record revenue of $318.3 million for Q1 2022, marking a 64% increase year-over-year and a 4% rise sequentially. The gross profit reached $178.2 million with a gross margin of 56%. Despite a net loss of $32.0 million, adjusted net income was $1.7 million. Operationally, Trulieve has an extensive retail network with 165 dispensaries and over 4.0 million square feet of cultivation capacity. The company expects 2022 revenue between $1.3 billion and $1.4 billion.
Trulieve Cannabis Corp. (CSE: TRUL; OTCQX: TCNNF) announced its participation in May 2022 events, highlighting a keynote speech by CEO Kim Rivers at Regenerative Cannabis Live on May 5, 2022. Trulieve is a leading, vertically integrated cannabis company operating in 11 states, focusing on growth and market expansion through its hub strategy. The company aims to provide innovative, high-quality products to enhance customer experiences and access to cannabis.
On April 28, 2022, Trulieve Cannabis Corp. announced that CEO Kim Rivers received the Women's Leadership Award from Green Market Report for her contributions in the cannabis industry. Rivers has driven significant business advancements, including leading retail expansion and the acquisition of Harvest Health. Trulieve also released its first ESG report, marking a milestone in corporate responsibility. The award ceremony took place during the Women's Summit in New York City, highlighting the importance of female leadership in the cannabis sector.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the completion of its acquisition of Greenhouse Wellness West Virginia Dispensaries LLC, which holds a dispensary permit in West Virginia. The acquisition, covered by the West Virginia Department of Health and Human Resources, involved a minimal cash payment. This deal enhances Trulieve's presence in West Virginia, where it now operates ten dispensaries in key locations and plans to open more in the near future. CEO Kim Rivers emphasized the company's commitment to community investment and improved patient access to high-quality products.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Zephyrhills, Florida on April 16, 2022. This dispensary aims to enhance patient access and features grand opening specials, including a 25% discount for registered patients. Trulieve is the leading medical cannabis provider in Florida, offering a wide range of THC and CBD products. The company emphasizes personalized patient care and support through trained retail employees. For more details on Trulieve's operations and other locations, visit trulieve.com.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Fort Myers, Florida, on April 13, 2022. The dispensary, located at 15620 Summerlin Rd, will feature grand opening festivities, including giveaways, food trucks, and a 25% discount for registered patients. As a leading medical cannabis provider, Trulieve offers a diverse range of THC and CBD products in Florida, with a focus on personalized patient care through trained staff. The company aims to build community relationships while expanding access to medical cannabis.